Voters in the Texas capital blocked a property tax increase that would have raised tens of millions of dollars to support homeless people and pay for other services.
Investors got to hear Novo Nordisk’s side of the Metsera bidding war drama for the first time on Wednesday, as the company reported third-quarter earnings. A rough quarter underscored the stakes for the Danish pharma.
Biohaven is proposing troriluzole for the treatment of spinocerebellar ataxia, a group of rare, genetic diseases that lead to the progressive loss of control over movement.
Arena launched with $500 million in early 2024 to fund basic biological research, from which it planned to spin out dedicated companies to focus on drug development.
Avalara announced that its Avi AI, first launched as a chatbot, is now an AI agent that will orchestrate an entirely new network of other AI agents that act as an agentic AI workforce for tax and compliance.